5 Stocks to Absolutely Avoid, JPMorgan Warns

(Adds the 18 other stock names that JPMorgan suggests avoiding.)

NEW YORK ( TheStreet) -- With the European debt crisis stretching on for two years, JPMorgan ( JPM) recommends that investors avoid the shares of U.S. companies that derive above-average levels of revenue on the Old Continent.

No one is sure about the eurozone's destiny, but most economists are certain it's headed into a recession, if it isn't already there. The U.S. economy, meanwhile, is facing a slowdown, though there have been signs that American consumers are spending more.

"The economy has been expanding moderately, notwithstanding some apparent slowing in global growth," the U.S. Federal Open Market Committee said in a statement at the end of its meeting Tuesday.

The turmoil in Europe has been reflected in the benchmark Stoxx Europe 600 Index, which is down 13% this year, compared with the S&P 500 Index, which is down only about 1%.

According to JPMorgan's equity strategists, 8% of S&P 500 companies' earnings per share come from Europe. JPMorgan did a screen for companies with a large amount of sales in Europe rated "underweight" or "neutral" by the investment bank and with a market value of more than $3 billion.

The five stocks that you should absolutely avoid are listed below. (The bank also has a list of shares worth buying.) They're rated "underweight" by JPMorgan and listed by most downside from analysts' price targets.

5. Exxon Mobil ( XOM)

Company Profile: Global oil company.

2011 Return: minus 10.1%

Current Price (Dec. 13): $80.53

JPMorgan's 2012 Price Target/(Downside) Upside: $88/up 9.3%

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

4. Computer Sciences Corp. ( CSC)

Company Profile: Information-technology and business-services company.

2011 Return: minus 49.7%

Current Price (Dec. 13): $24.93

JPMorgan's 2012 Price Target/(Downside) Upside: $27/up 8.3%


3. Edwards Lifesciences ( EW)

Company Profile: Offers products and technologies that treat advanced cardiovascular disease.

2011 Return: minus 17%

Current Price (Dec. 13): $67.13

JPMorgan's 2012 Price Target/(Downside) Upside: $70/up 4.3%

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

2. First Solar ( FSLR)

Company Profile: First Solar makes solar panels. The company yesterday slashed its full-year forecast.

2011 Return: minus 67.3%

Current Price (Dec. 13): $42.57

JPMorgan's 2012 Price Target/(Downside) Upside: $40/minus 6%


1. Garmin ( GRMN)

Company Profile: Makes navigation devices enabled by global positioning technology.

2011 Return: up 23.9%

Current Price (Dec. 13): $38.38

JPMorgan's 2012 Price Target/(Downside) Upside: $30.50/minus 20.5%

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

>>To see these stocks in action, visit the 5 Stocks JPMorgan Warns to Absolutely Avoid portfolio on Stockpickr.

Other stocks JPMorgan suggests avoiding include: PartnerRe ( PRE), Phillip Morris International ( PM), Owens-Illinois ( OI), Pall Corp. ( PLL), Molson Coors Brewing Co. ( TAP), Mettler-Toledo International ( MTD), Qiagen ( QGEN), Ansys ( ANSS), Biogen Idec ( BIIB), Marsh & McLennan ( MMC), Becton Dickinson ( BDX), Illinois Tool Works ( ITW), Coca-Cola ( CCE), Waters Corp. ( WAT), Weight Watchers International ( WTW), Willis Group ( WSH), eBay ( EBAY), Ford ( F).

-- Written by Lindsey Bell in New York.

>To follow the writer on Twitter, go to Lindsey Bell.